Experienced in Gliosarcoma

Dr. Patricia C. Griffin

Radiation Oncology
101 E Wood St, 
Spartanburg, SC 
Experienced in Gliosarcoma
101 E Wood St, 
Spartanburg, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Patricia Griffin is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Griffin is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Breast Cancer, Small Cell Lung Cancer (SCLC), Angiosarcoma, and ALK-Positive Non-Small Cell Lung Cancer.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in SC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

101 E Wood St, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Radiation
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2024
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: August 05, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 7 Less Clinical Trials

3 Total Publications

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 27, 2017
Similar Doctors
Distinguished in Gliosarcoma
Dr. Jeremy M. Kilburn
Radiation Oncology
Distinguished in Gliosarcoma
Dr. Jeremy M. Kilburn
Radiation Oncology

Spartanburg Medical Center

2755s Hwy 14, 
Greer, SC 
 (17.5 miles away)
864-849-9333
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeremy Kilburn is a Radiation Oncologist in Greer, South Carolina. Dr. Kilburn has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Lung Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Prostate Cancer. Dr. Kilburn is currently accepting new patients.

Advanced in Gliosarcoma
Dr. Daniel B. Fried
Radiation Oncology
Advanced in Gliosarcoma
Dr. Daniel B. Fried
Radiation Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Fried is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Fried is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Astrocytoma, and Lung Cancer. Dr. Fried is currently accepting new patients.

Distinguished in Gliosarcoma
Dr. John J. O'connell
Radiation Oncology
Distinguished in Gliosarcoma
Dr. John J. O'connell
Radiation Oncology

Prisma Health University Medical Group

340 Medical Pkwy, 
Greer, SC 
 (17.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John O'connell is a Radiation Oncologist in Greer, South Carolina. Dr. O'connell is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Posterior Fossa Tumor, Astrocytoma, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. O'connell is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Griffin's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 37 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile